Moreover, IL-8 levels can identify the presence of significant fibrosis in NASH patients (68), and are elevated in NAFLD patients when compared to both obese and non-obese controls (61). The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.